BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 265 filers reported holding BIONTECH SE in Q3 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,088,000 | -42.4% | 9,864 | -42.9% | 0.00% | -50.0% |
| Q2 2023 | $1,888,000 | +2.3% | 17,285 | +15.8% | 0.00% | 0.0% |
| Q1 2023 | $1,846,000 | +89.7% | 14,927 | +131.2% | 0.00% | +100.0% |
| Q4 2022 | $973,000 | +30.8% | 6,455 | +16.3% | 0.00% | 0.0% |
| Q3 2022 | $744,000 | -19.5% | 5,552 | -10.3% | 0.00% | 0.0% |
| Q2 2022 | $924,000 | -12.6% | 6,187 | -0.0% | 0.00% | 0.0% |
| Q1 2022 | $1,057,000 | -76.1% | 6,189 | -64.0% | 0.00% | -80.0% |
| Q4 2021 | $4,426,000 | -18.6% | 17,168 | -13.8% | 0.01% | -33.3% |
| Q3 2021 | $5,438,000 | +2394.5% | 19,917 | +1936.5% | 0.02% | +1400.0% |
| Q2 2021 | $218,000 | -15.8% | 978 | -58.9% | 0.00% | 0.0% |
| Q1 2021 | $259,000 | -37.1% | 2,381 | -60.0% | 0.00% | -50.0% |
| Q3 2020 | $412,000 | +6.5% | 5,958 | +2.7% | 0.00% | 0.0% |
| Q2 2020 | $387,000 | – | 5,804 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 148,674 | $16,151,943 | 19.26% |
| Quinn Opportunity Partners LLC | 659,383 | $71,635,369 | 9.22% |
| Systrade AG | 50,000 | $5,432,000 | 4.70% |
| Crocodile Capital Partners GmbH | 29,586 | $3,214,223 | 3.03% |
| ALTRINSIC GLOBAL ADVISORS LLC | 700,421 | $76,093,737 | 2.94% |
| Temasek Holdings (Private) Ltd | 4,518,080 | $490,844,211 | 2.92% |
| PARUS FINANCE (UK) Ltd | 25,662 | $2,787,920 | 1.74% |
| FLOSSBACH VON STORCH AG | 3,513,215 | $381,675,678 | 1.68% |
| AtonRa Partners | 4,707 | $511,368 | 1.07% |
| Baader Bank Aktiengesellschaft | 135,093 | $14,617,456 | 0.99% |